Diabetes Remission With GLP-1 Drugs: Is It Actually Possible?
Review examines whether GLP-1 drugs can achieve true diabetes remission — sustained normalization of blood sugar without medication — and identifies who is most likely to achieve it.
Quick Facts
What This Study Found
Review examines whether GLP-1 drugs can achieve true diabetes remission — sustained normalization of blood sugar without medication — and identifies who is most likely to achieve it.
Key Numbers
India has alarming and rising diabetes prevalence. Remission defined as sustained normal blood sugar without medication.
How They Did This
In publication.
Why This Research Matters
Relevant to peptide therapeutics.
The Bigger Picture
Advances peptide evidence.
What This Study Doesn't Tell Us
In publication.
Questions This Raises
- ?Long-term implications?
- ?Evidence comparison?
- ?Next steps?
Trust & Context
- Key Stat:
- Key finding Review examines whether GLP-1 drugs can achieve true diabetes remission — sustained normalization of
- Evidence Grade:
- Based on design.
- Study Age:
- Published in 2025.
- Original Title:
- Achieving Diabetes Remission: Current Guidelines and Emerging Pharmacotherapies in India.
- Published In:
- The Journal of the Association of Physicians of India, 73(10), 83-86 (2025)
- Authors:
- Arpan, Singh, Navrajbir, Bali, Kusum, Singh, Tarundeep
- Database ID:
- RPEP-09985
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What does this mean?
Review examines whether GLP-1 drugs can achieve true diabetes remission — sustained normalization of blood sugar without medication — and identifies who is most likely to achieve it.
How reliable?
Consult publication.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09985APA
Arpan; Singh, Navrajbir; Bali, Kusum; Singh, Tarundeep. (2025). Achieving Diabetes Remission: Current Guidelines and Emerging Pharmacotherapies in India.. The Journal of the Association of Physicians of India, 73(10), 83-86. https://doi.org/10.59556/japi.73.1184
MLA
Arpan, et al. "Achieving Diabetes Remission: Current Guidelines and Emerging Pharmacotherapies in India.." The Journal of the Association of Physicians of India, 2025. https://doi.org/10.59556/japi.73.1184
RethinkPeptides
RethinkPeptides Research Database. "Achieving Diabetes Remission: Current Guidelines and Emergin..." RPEP-09985. Retrieved from https://rethinkpeptides.com/research/arpan-2025-achieving-diabetes-remission-current
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.